Acquisition (code A) of 1,288 shares at $9.70 per share.
Reporting Person Frank Steven · Transaction Code A
Traded Aug 31, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0000882796-26-000057 · filed 2026-09-02 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "BIOCRYST PHARMACEUTICALS INC (BCRX)." Disclosed 2026-09-02. https://desqlong.com/cards/0000882796-26-000057-1 (retrieved 2026-09-26).